Summary
To determine the effect of age and comorbid diseases on treatment choice and survival, the medical records of 300 breast cancer patients of 55 years and older were reviewed. All patients were admitted to the Netherlands Cancer Institute (NKI) for first treatment between 1980 and 1987. Patients were classified according to severity level of comorbid diseases. Physicians were found to treat women of 75 years and older less often with adjuvant radiotherapy after a mastectomy, and more often to employ only primary endocrine treatment for local stage disease, as compared with younger patients. According to the treatment guidelines of the institute, the study sample was divided into patients who received standard vs. non-standard treatment. The treatment of 38 women (13.1%) did not correspond with the guidelines. Of these, 84% were 75 years and older and 50% had a severe comorbidity status. Logistic regression analysis indicated that advanced age, per se, was a better indicator of the risk of not being treated according to protocol than the comorbidity status. Cox multivariate analyses demonstrated that neither the severity of the comorbidity status nor the differences in treatment between younger and older patients had a significant effect on the risk of dying from breast cancer or on the risk of developing recurrences. In this analysis, age 75 years or more proved to be a significant and independent predictor of a worse overall and disease-specific survival as compared to age between 65–74 years.
Similar content being viewed by others
References
STG: Cancer in the Netherlands, vol. 1. Kluwer Academic, Dordrecht, 1988
Muir C, Waterhouse J, Mack T, Powell J, Whelan S: Cancer incidence in five continents, vol. V. IARC scientific publication no. 88, Lyon, 1987, pp 574–580
Donegan WL: Treatment of breast cancer in the elderly. In: Yancik R, Carbone PP, Bradford Patterson W, Steel K, Terry WD (eds) Perspectives on Prevention and Treatment of Cancer in the Elderly. Raven Press, New York, 1983, pp 83–96
Samet J, Hunt WC, Key C, Humble CG, Goodwin JS: Choice of cancer therapy varies with age of patient. JAMA 255: 3385–3390, 1986
Greenfield S, Blanco DM, Elashoff RM, Ganz PA: Patterns of care related to age of breast cancer patients. JAMA 257: 2766–2770, 1987
Allen K, Cox E, Manton K, Cohen HJ: Breast cancer in the elderly: Current patterns of care. J Am Geriatr Soc 34: 637–642, 1986
Chu J, Diehr P, Feigl, Glaefke G, Begg C, Glicksman A, Ford L: The effect of age on the care of women with breast cancer in community hospitals. J Geront 42: 185–90, 1987
Silliman RA, Guadagnoli E, Weitberg AB, Mor V: Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Geront 44: 46–50, 1989
Yancik R, Ries LG, Yates JW: Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival. Cancer 63: 976–981, 1989
Bergman L, Dekker G, van Leeuwen FE,et al.: The effect of age on treatment choice and survival in elderly breast cancer patients. Cancer 67: 2227–34, 1991
Somers R, van Leeuwen FE: Behandelingsrichtlijnen. Antoni van Leeuwenhoek huis, Amsterdam, 1986
International Union Against Cancer: TNM classifications of breast cancer. Harme MH (ed), Geneva, 1982
Baak JPA, van Dop H, Kurver PHJ, Hermans J: The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374–382, 1985
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomised clinical trials requiring prolonged observations of each patients. II. Analysis and examples. Br J Cancer 35: 1–39, 1977
Cox DR: Regression models and life-tables. J Royal Stat Soc 34: 187–220, 1972
Zoetmulder FAN: Primary treatment of operable breast cancer in the elderly with Tamoxifen. In: ten Bokkel Huinink WW (ed) Cancer in the Elderly. Excerpta Medica, Amsterdam, 1988, pp 51–57
Robertson JFR, Todd JH, Ellis IO, Elston CW, Blamey RW: Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. Br Med J 297: 510–514, 1988
Gazet JC, Ford HT, Bland JM, Markopoulos CH, Combes RC, Dixon RC: Prospective randomised trial of Tamoxifen versus surgery in elderly patients with breast cancer. Lancet: 679–681, 1988
Feinstein AR, Wells CK: A clinical-severity staging system for patients with lung cancer. Medicine 69: 1–33, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergman, L., Dekker, G., van Kerkhoff, E.H. et al. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Tr 18, 189–198 (1991). https://doi.org/10.1007/BF01990035
Issue Date:
DOI: https://doi.org/10.1007/BF01990035